Relationship between transforming growth factor β1 and anti-fibrotic effect of interleukin-10

World Journal of Gastroenterology

Volumn 12, Issue 15, 2006, Pages 2357-2362

  Shi, Mei Na ^a   Huang, Yue Hong ^a   Zheng, Wei Da ^a   Zhang, Li Juan ^a   Chen, Zhi Xin ^a   Wang, Xiao Zhong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Hepatic stellate cells; Interleukin 10; Transforming growth factor 1

Indexed keywords

ANTIFIBROTIC AGENT; CARBON TETRACHLORIDE; INTERLEUKIN 10; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL;

EID: 33646448434     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i15.2357     Document Type: Article

References (26)

1. Du WD, Zhang YE, Zhai WR, Zhou XM. Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 1999; 5: 397-403
2. Wang JY, Guo JS, Yang CQ. Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol 2002; 8: 901-907
3. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001; 21: 437-451
4. Wang FS, Wu ZZ. Current situation in studies of gene therapy of liver cirrhosis and liver fibrosis. Shijie Huanren Xiaohua Zazhi 2000; 8: 371-373
5. Dai WJ, Jiang HC. Advances in gene therapy of liver cirrhosis: a review. World J Gastroenterol 2001; 7: 1-8
6. Xiang DD, Wei YL, Li QF. Molecular mechanism of transforming growth factor b1 on Ito cell. Shijie Huanren Xiaohua Zazhi 1999; 7: 980-981
7. Zhang LJ, Wang XZ, Huang YH, Chen ZX. The effects of CGRP, AgII and ET on the liver fibrosis rats. Shijie Huaren Xiaohua Zazhi 2001; 9: 457-459
8. Morrow JD, Awad JA, Kato T, Takahashi K Badr KF, Roberts LJ 2nd, Burk RF. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest 1992; 90: 2502-2507
9. Nelson DR, Lauwers GY, Lau JY, Davis GL. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 2000; 118: 655-660
10. Zheng WD, Wang XZ, Zhang LJ, Shi MN. A simple and reliable method of isolating rat hepatic stellate cells. Fujian Yikedaxue Xuebao 2002; 38: 71-73
11. Schuppan D, Strobel D, Hahn EG. Hepatic fibrosis therapeutic strategies. Digestion 1998; 59: 385-390
12. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998; 18: 2-13
13. Gressner AM. The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res 1998; 292: 447-452
14. Ledeboer A, Breve JJ, Poole S, Tilders FJ, Van Dam AM. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glut 2000; 30: 134-142
15. Marques CP, Hu S, Sheng W, Cheeran MC, Cox D, Lokensgard JR. Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia 2004; 47: 358-366
16. Mitchell MD, Simpson KL, Keelan JA. Paradoxical proinflammatory actions of interleukin-10 in human amnion: potential roles in term and preterm labour. J Clin Endocrinol Metab 2004; 89: 4149-4152
17. Zhang LJ, Yu JP, Li D, Huang YH, Chen ZX, Wang XZ. Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats. World J Gastroenterol 2004; 10: 77-81
18. Wang XZ, Zhang LJ, Li D, Huang YH, Chen ZX, Li B. Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4. World J Gastroenterol 2003; 9: 539-543
19. Flisiak R, Pytel-Krolczuk B, Prokopowicz D. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis. Cytokine 2000;12: 677-681
20. Lee BS, Kim NJ, Jeong HY, Lee HY, Kang DY, Noh SM. Changes in serum cytokine concentration: a morphological study of liver cirrhosis induced by common bile duct ligation in rats. Korean J Intern Med 2003; 18: 6-12
21. Flisiak R, Prokopowicz D. Transforming growth factor-beta1 as a surrogate marker of hepatic dysfunction in chronic liver diseases. Clin Chem Lab Med 2000; 38: 1129-1131
22. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000; 32: 247-255
23. Xu XB, He ZP, Liang ZQ, Leng XS. [Obstruction of TGF-beta1 signal transduction by anti-Smad4 gene can therapy experimental liver fibrosis in the rat. Zhonghua Ganzangbing Zazhi 2004; 12: 263-266
24. Wu XR, Lv MH, Wang Q, Shi SS, Guo WD. The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis. Zhonghua Ganzangbing Za zhi 2004; 12: 400-402
25. Ma C, Chegini N. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1. Mol Hum Reprod 1999; 5: 950-954
26. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 1999; 30: 48-60